Polysorbate 80 surface modified PLGA nanoparticles: an in-vitro evaluation of cellular uptake and cytotoxicity on neuro-2a cells

References

• Alshetaili, A.S., 2021. Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines. Saudi journal of biological sciences, 28 (9), 5065–5073.
   PubMed Web of Science ®Google Scholar
• Anwer, M.K., et al., 2019. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. International journal of nanomedicine, 14, 1587–1595.
   PubMed Web of Science ®Google Scholar
• Anzar, N., et al., 2018. Preparation, evaluation and pharmacokinetic studies of spray dried PLGA polymeric submicron particles of simvastatin for the effective treatment of breast cancer. Journal of molecular liquids, 249, 609–616.
   Web of Science ®Google Scholar
• Ayyoob, M., 2018. Effect of chemical composition variant and oxygen plasma treatments on the wettability of plga thin films, synthesized by direct copolycondensation. Polymers, 10, 1132.
   PubMed Web of Science ®Google Scholar
• Balakrishnan, K., et al., 2021. Bioformulated hesperidin-loaded PLGA nanoparticles counteract the mitochondrial-mediated intrinsic apoptotic pathway in cancer cells. Journal of inorganic and organometallic polymers and materials, 31 (1), 331–343.
   Web of Science ®Google Scholar
• Blasi, P., et al., 2007. Solid lipid nanoparticles for targeted brain drug delivery. Advanced drug delivery reviews, 59 (6), 454–477.
   PubMed Web of Science ®Google Scholar
• Borm, P.J., et al., 2006. The potential risks of nanomaterials: a review carried out for ECETOC. Particle and fibre toxicology, 3, 11.
   PubMed Web of Science ®Google Scholar
• Boyer, W.F., and Feighner, J.P., 1992. An overview of paroxetine. The journal of clinical psychiatry, 53 Suppl, 3–6.
   PubMed Web of Science ®Google Scholar
• Chalikwar, S.S., et al., 2013. Self-Assembled, Chitosan Grafted PLGA Nanoparticles for Intranasal Delivery: Design, Development and Ex Vivo Characterization. Polymer-plastics technology and engineering, 52 (4), 368–380.
   Web of Science ®Google Scholar
• Deepika, D., et al., 2019. Intranasal drug delivery of frovatriptan succinate–Loaded polymeric nanoparticles for brain targeting. Journal of pharmaceutical sciences, 108 (2), 851–859.
   PubMed Web of Science ®Google Scholar
• Elsewedy, H.S., et al., 2020. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles. Drug delivery, 27 (1), 1134–1146.
   PubMed Web of Science ®Google Scholar
• Escalona-Rayo, O., et al., 2019. Rapamycin-loaded polysorbate 80-coated PLGA nanoparticles: Optimization of formulation variables and in vitro anti-glioma assessment. Journal of drug delivery science and technology, 52, s488–499.
   Web of Science ®Google Scholar
• Fahmy, H.M., et al., 2020. Thymoquinone-encapsulated chitosan nanoparticles coated with polysorbate 80 as a novel treatment agent in a reserpine-induced depression animal model. Physiology & behavior, 222, 112934.
   PubMed Web of Science ®Google Scholar
• Gaignaux, A., et al., 2012. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. International journal of pharmaceutics, 437 (1–2), 20–28.
   PubMed Web of Science ®Google Scholar
• Ibrahim, W.N., Muizzuddin Bin Mohd Rosli, L., and Doolaanea, A.A., 2020. Formulation, cellular uptake and cytotoxicity of thymoquinone-loaded PLGA nanoparticles in malignant melanoma cancer cells. International journal of nanomedicine, 15, 8059–8074.
   PubMed Web of Science ®Google Scholar
• Jia, L., et al., 2013. In-vitro and in-vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes. International journal of pharmaceutics, 445 (1–2), 12–19.
   PubMed Web of Science ®Google Scholar
• Jia, L.-J., et al., 2010. Preparation and characterization of silybin-loaded nanostructured lipid carriers. Drug delivery, 17 (1), 11–18.
   PubMed Web of Science ®Google Scholar
• Jonderian, A., and Maalouf, R., 2016, Formulation and in vitro interaction of rhodamine-B loaded PLGA nanoparticles with cardiac myocytes. Frontiers in pharmacology, 7, 458.
   PubMed Web of Science ®Google Scholar
• Jose, S., et al., 2014. Surface modified PLGA nanoparticles for brain targeting of Bacoside-A. European journal of pharmaceutical sciences : official journal of the european federation for pharmaceutical sciences, 63, 29–35.
   PubMed Web of Science ®Google Scholar
• Joshi, A.S., Gahane, A., and Thakur, A.K., 2016. Deciphering the mechanism and structural features of polysorbate 80 during adsorption on PLGA nanoparticles by attenuated total reflectance – Fourier transform infrared spectroscopy. RSC advances, 6 (110), 108545–108557.
   Web of Science ®Google Scholar
• Joshi, G., Kumar, A., and Sawant, K., 2014. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery. European journal of pharmaceutical sciences : official journal of the European federation for pharmaceutical sciences, 60, 80–89.
   PubMed Web of Science ®Google Scholar
• Khalid Anwer, M., et al., 2016. Development and evaluation of PLGA polymer based nanoparticles of quercetin. International journal of biological macromolecules, 92, 213–219.
   PubMed Web of Science ®Google Scholar
• Khuroo, T., et al., 2014. Zeenat Iqbal,Topotecan–tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential. International journal of pharmaceutics, 473 (1–2), 384–394.
   PubMed Web of Science ®Google Scholar
• Khuroo, T., et al., 2018. Simultaneous delivery of paclitaxel and erlotinib from dual drug loaded PLGA nanoparticles: formulation development, thorough optimization and in vitro release. Journal of molecular liquids, 257, 52–68.
   Web of Science ®Google Scholar
• Khuroo, T., et al., 2022. Qbd based and box-Behnken design assisted oral delivery of stable lactone (active) form of Topotecan as PLGA nanoformulation: cytotoxicity, pharmacokinetic, in vitro, and ex vivo gut permeation studies. Journal of drug delivery science and technology, 77, 103850.
   Web of Science ®Google Scholar
• Kreuter, J., 2001. Nanoparticulate systems for brain delivery of drugs. Advanced drug delivery reviews, 47 (1), 65–81.
   PubMed Web of Science ®Google Scholar
• Lalani, J., et al., 2015. Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management. AAPS PharmSciTech, 16 (2), 413–427.
   PubMed Web of Science ®Google Scholar
• Madani, F., et al., 2020. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: formulation development and in vitro antitumor activity evaluation. Life sciences, 256, 117943.
   PubMed Web of Science ®Google Scholar
• Md, S., et al., 2014. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug development and industrial pharmacy, 40 (2), 278–287.
   PubMed Web of Science ®Google Scholar
• Meng, Q., et al., 2018. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. International journal of nanomedicine, 13, 705–718.
   PubMed Web of Science ®Google Scholar
• Monge, M., et al., 2020. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 156, 155–164.
   PubMed Web of Science ®Google Scholar
• Nguyen, V.H., and Lee, B.J., 2017. Protein corona: a new approach for nanomedicine design. International journal of nanomedicine, 12, 3137–3151.
   PubMed Web of Science ®Google Scholar
• Nigam, K., et al., 2019. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles. Drug delivery and translational research, 9 (5), 879–890.
   PubMed Web of Science ®Google Scholar
• Pandey, Y.R., et al., 2016. 1 Intranasal delivery of paroxetine nanoemulsion via the olfactory region for the management of depression: formulation, behavioural and biochemical estimation. Nanotechnology, 27 (2), 025102.
   PubMed Web of Science ®Google Scholar
• Rasmussen, M.K., Pedersen, J.N., and Marie, R., 2020. Size and surface charge characterization of nanoparticles with a salt gradient. Nature communications, 11 (1), 2337.
   PubMed Web of Science ®Google Scholar
• Ravisankar, P., et al., 2016. Validated UV spectrophotometric method for quantitative analysis of paroxetine in bulk and pharmaceutical dosage form. Der pharmacia lettre, 8 (3), 254–260.
   Google Scholar
• Schroder, U., and Sabel, B.A., 1996. Nanos, adrug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain res,. 710 (1–2), 121–124.
   PubMed Web of Science ®Google Scholar
• Seju, U., Kumar, A., and Sawant, K.K., 2011. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta biomaterialia, 7 (12), 4169–4176.
   PubMed Web of Science ®Google Scholar
• Sempf, K., et al., 2013. Adsorption of plasma proteins on uncoated PLGA nanoparticles. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 85 (1), 53–60.
   PubMed Web of Science ®Google Scholar
• Shah, P., et al., 2021. Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study. Artificial cells, nanomedicine, and biotechnology, 49 (1), 511–522.
   PubMed Web of Science ®Google Scholar
• Sharma, D., et al., 2014. Formulation and optimization of polymeric nanoparticles for intranasal delivery of lorazepam using Box-Behnken design: in vitro and in vivo evaluation. Biomed research international. 2014, 1–14.
   Web of Science ®Google Scholar
• Sharma, S., and Dang, S., 2020. Neuropsychological disorders and their nanocarriers. Current pharmaceutical design, 26 (19), 2247–2256. PMID: 32091327.
   PubMed Web of Science ®Google Scholar
• Sharma, S., and Dang, S., 2020. Paroxetine loaded PLGA nanoparticles. Materials today: Proceedings, 28 (1), 205–210.
   Google Scholar
• Sharma, S., and Dang, S., 2023. Nanocarrier based drug delivery to brain: interventions of surface modification. Current neuropharmacology, 21 (3), 517–535.
   PubMed Web of Science ®Google Scholar
• Sun, D., et al., 2015.Polysorbate 80-coated PLGA nanoparticles fimprove the permeability of acetylpuerarin and enhance its brain-protective effects in rats. The journal of pharmacy and pharmacology, 67 (12), 1650–1662.
   PubMed Web of Science ®Google Scholar
• Tang, S., et al., 2019. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease. Drug delivery, 26 (1), 700–707.
   PubMed Web of Science ®Google Scholar
• Tzeyung, A.S., et al., 2019. Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery. Pharmaceutics, 11 (1), 26.
   PubMed Web of Science ®Google Scholar
• Vance, A., 2008. A current treatment approach for attention deficit hyperactivity disorder. Australian Prescriber, 31, 129–132.
   Google Scholar
• V., A., Bagul., et al. 2023. Development and validation of simple and rapid uv spectroscopic method for estimation of clonidine hydrochloride in tablet dosage form. Journal of Emerging Technologies and Innovative Research (JETIR), 10 (3), 152–b164.
   Google Scholar
• Verma, D., et al., 2017. Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: Optimization, in vitro characterization and stability assessment. Journal of molecular liquids, 242, 382–394.
   Web of Science ®Google Scholar
• Wadell, C., 1999. Nasal drug delivery – In vitro studies on factors influencing permeability and implication on absorption. Drug metabolism revi, 7, 197–206.
   Google Scholar
• Yadav, K.S., and Sawant, K.K., 2010. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles. AAPS PharmSciTech, 11 (3), 1456–1465.
   PubMed Web of Science ®Google Scholar
• Yasaei, R., and Saadabadi, A., 2022. Clonidine. [Updated 2022 Jul 19]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459124/
   Google Scholar
• Yusuf, M., et al., 2016. Polysorbate-80-coated, polymeric curcumin nanoparticles for in vivo anti-depressant activity across BBB and envisaged biomolecular mechanism of action through a proposed pharmacophore model. Journal of microencapsulation, 33 (7), 646–655.
   PubMed Web of Science ®Google Scholar